Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol vs Bleomycin in Infantile Hemangioma
NCT05327309Completed
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Start
- May 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of bleomycin in infantile hemangioma (IH), sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Primary endpoints: Change in size of hemangioma at 6 months and Efficacy in terms of size regression at 6 months. Started May 2015; status: completed.
02
Drugs
bleomycin
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT05327309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327309.